Machine Learning Metabolomics Profiling of Dietary Interventions from a Six-Week Randomised Trial

被引:0
|
作者
Kouraki, Afroditi [1 ,2 ,3 ]
Nogal, Ana [4 ,5 ]
Nocun, Weronika [1 ]
Louca, Panayiotis [4 ,6 ]
Vijay, Amrita [1 ]
Wong, Kari [7 ]
Michelotti, Gregory A. [7 ]
Menni, Cristina [4 ]
Valdes, Ana M. [1 ,2 ,3 ,8 ]
机构
[1] Univ Nottingham, Sch Med, Acad Unit Injury Recovery & Inflammat Sci Rheumato, Nottingham NG7 2UH, England
[2] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2UH, England
[3] Univ Nottingham, Nottingham NG7 2UH, England
[4] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England
[5] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Newcastle Univ, Populat Hlth Sci Inst, Human Nutr & Exercise Res Ctr, Newcastle Upon Tyne NE2 4HH, England
[7] Metabolon Inc, Res Triangle Pk, NC 27560 USA
[8] Univ Nottingham, Pain Ctr Versus Arthrit, Nottingham NG5 1PB, England
关键词
fibre; omega-3; metabolomics; machine learning; indoleproprionate; gut microbiome; GUT MICROBIOME;
D O I
10.3390/metabo14060311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolomics can uncover physiological responses to prebiotic fibre and omega-3 fatty acid supplements with known health benefits and identify response-specific metabolites. We profiled 534 stool and 799 serum metabolites in 64 healthy adults following a 6-week randomised trial comparing daily omega-3 versus inulin supplementation. Elastic net regressions were used to separately identify the serum and stool metabolites whose change in concentration discriminated between the two types of supplementations. Random forest was used to explore the gut microbiome's contribution to the levels of the identified metabolites from matching stool samples. Changes in serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoate and indoleproprionate levels accurately discriminated between fibre and omega-3 (area under the curve (AUC) = 0.87 [95% confidence interval (CI): 0.63-0.99]), while stool eicosapentaenoate indicated omega-3 supplementation (AUC = 0.86 [95% CI: 0.64-0.98]). Univariate analysis also showed significant increases in indoleproprionate with fibre, 3-carboxy-4-methyl-5-propyl-2-furanpropanoate, and eicosapentaenoate with omega-3. Out of these, only the change in indoleproprionate was partly explained by changes in the gut microbiome composition (AUC = 0.61 [95% CI: 0.58-0.64] and Rho = 0.21 [95% CI: 0.08-0.34]) and positively correlated with the increase in the abundance of the genus Coprococcus (p = 0.005). Changes in three metabolites discriminated between fibre and omega-3 supplementation. The increase in indoleproprionate with fibre was partly explained by shifts in the gut microbiome, particularly Coprococcus, previously linked to better health.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] The DAHANCA 6 randomised trial: Five versus six fractions per week of radiotherapy in glottic cancer
    Lyhne, N.
    Primdahl, H.
    Kristensen, C. A.
    Andersen, E.
    Johansen, J.
    Andersen, L. J.
    Evensen, J.
    Overgaard, J.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S20 - S21
  • [42] Altering Knee Abduction Angular Impulse Using Wedged Insoles for Treatment of Patellofemoral Pain in Runners: A Six-Week Randomized Controlled Trial
    Lewinson, Ryan T.
    Wiley, J. Preston
    Humble, R. Neil
    Worobets, Jay T.
    Stefanyshyn, Darren J.
    PLOS ONE, 2015, 10 (07):
  • [43] Safety and efficacy of phacoemulsification compared with manual small-incision cataract surgery by a randomized controlled clinical trial - Six-week results
    Gogate, PM
    Kulkarni, SR
    Krishnaiah, S
    Deshpande, RD
    Joshi, SA
    Palimkar, A
    Deshpande, MD
    OPHTHALMOLOGY, 2005, 112 (05) : 869 - 874
  • [44] CACNA1C polymorphisms Impact Cognitive Recovery in Patients with Bipolar Disorder in a Six-week Open-label Trial
    Kangguang Lin
    Guiyun Xu
    Lingling Shi
    Weicong Lu
    Lijie Guan
    Huiyi Ouyang
    Kun Chen
    Yamei Dang
    Libing Zhou
    Kwok-Fai So
    Scientific Reports, 7
  • [45] Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial
    Kumar, Navneet
    Abichandani, L. G.
    Thawani, Vijay
    Gharpure, K. J.
    Naidu, M. U. R.
    Ramana, G. Venkat
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [46] A six-week group program of emotion focused family therapy for parents of children with mental health challenges: protocol for a randomized controlled trial
    Seddon, Jessica A.
    Reaume, Chelsea L.
    Thomassin, Kristel
    BMC PSYCHIATRY, 2025, 25 (01)
  • [47] Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis - A randomized, double-blind six-week trial with eighteen-week extension
    Furst, DE
    Lindsley, H
    Baethge, B
    Botstein, GR
    Caldwell, J
    Dietz, F
    Ettlinger, R
    Golden, HE
    McLaughlin, GE
    Moreland, LW
    Roberts, WN
    Rooney, TW
    Rothschild, B
    Sack, M
    Sebba, AI
    Weisman, M
    Welch, KE
    Yocum, D
    ARTHRITIS AND RHEUMATISM, 1999, 42 (02): : 357 - 365
  • [48] The Molecular Phenotype of Six-Week Protocol Biopsies from Human Renal Allografts: Reflections of Prior Injury but Not Future Course
    Mengel, M.
    Chang, J.
    Kayser, D.
    Gwinner, W.
    Schwarz, A.
    Einecke, G.
    Broecker, V.
    Famulski, K.
    De Freitas, D.
    Hidalgo, L.
    Haller, H.
    Sis, B.
    Halloran, P.
    LABORATORY INVESTIGATION, 2011, 91 : 348A - 348A
  • [49] The Molecular Phenotype of Six-Week Protocol Biopsies from Human Renal Allografts: Reflections of Prior Injury but Not Future Course
    Mengel, M.
    Chang, J.
    Kayser, D.
    Gwinner, W.
    Schwarz, A.
    Einecke, G.
    Broecker, V.
    Famulski, K.
    De Freitas, D.
    Hidalgo, L.
    Haller, H.
    Sis, B.
    Halloran, P.
    MODERN PATHOLOGY, 2011, 24 : 348A - 348A
  • [50] Biomarker discovery and metabolic profiling in serum of cardiovascular disease patients with untargeted metabolomics and machine learning
    Shen, Xia
    Guo, Shuyuan
    Liang, Ningning
    Zhao, Mingming
    Wang, Chun
    Li, Zi
    Yan, Dewen
    Zheng, Lemin
    Yin, Huiyong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (06):